The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, according to data from two international phase III clinical trials show that was ...More
The Wall Street Journal reported that the U.S. Food and Drug Administration (FDA) issued an alert June 11 about Wyeth’s kidney-transplant drug Rapamune saying "the safety and efficacy of this drug in liver or lung transplant patients have not been established." Rapamune is ...More